LENZ Therapeutics, Inc.
LENZ
$38.79
-$0.89-2.24%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 15.14% | 18.77% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 29.09% | 11.21% | |||
| Operating Income | 0.44% | -11.21% | |||
| Income Before Tax | 1.42% | -15.56% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -2.00% | -15.55% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -2.00% | -15.55% | |||
| EBIT | 0.44% | -11.21% | |||
| EBITDA | 0.34% | -11.15% | |||
| EPS Basic | 0.00% | -15.41% | |||
| Normalized Basic EPS | 3.34% | -15.40% | |||
| EPS Diluted | 0.00% | -15.41% | |||
| Normalized Diluted EPS | 3.34% | -15.40% | |||
| Average Basic Shares Outstanding | 2.01% | 0.12% | |||
| Average Diluted Shares Outstanding | 2.01% | 0.12% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||